Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1582
Source ID: NCT01345656
Associated Drug: Bay94-8862
Title: BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease
Acronym: ARTS
Status: COMPLETED
Study Results: NO
Results:
Conditions: Heart Failure
Interventions: DRUG: BAY94-8862|DRUG: BAY94-8862|DRUG: BAY94-8862|DRUG: BAY94-8862|DRUG: Placebo|DRUG: Spironolactone
Outcome Measures: Primary: Change of serum potassium, 4 weeks | Secondary: Change in serum magnesium, Day 8, Day 15, Day 22, Day 29|Change in blood pressure, Day 8, Day 15, Day 22, Day 29|Change in heart rate, Day 8, Day 15, Day 22, Day 29
Sponsor/Collaborators: Sponsor: Bayer
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 457
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2011-05-09
Completion Date: 2012-07-16
Results First Posted:
Last Update Posted: 2022-02-10
Locations: Linz, Oberösterreich, 4010, Austria|Graz, Steiermark, 8036, Austria|Wien, 1100, Austria|Brasschaat, 2930, Belgium|Bruxelles - Brussel, 1200, Belgium|Roeselare, 8800, Belgium|Brno, 625 00, Czechia|Liberec, 460 63, Czechia|Praha 2, 12808, Czechia|Praha 5, 15030, Czechia|Copenhagen Ø, 2100, Denmark|Esbjerg, 6700, Denmark|Frederiksberg, 2000, Denmark|Hellerup, 2900, Denmark|Herlev, 2730, Denmark|Hvidovre, 2650, Denmark|København NV, 2400, Denmark|Køge, 4600, Denmark|Odense, 5000, Denmark|Svendborg, 5700, Denmark|Viborg, 8800, Denmark|Helsinki, FIN-00260, Finland|Jyväskylä, FI-40620, Finland|Turku, FIN-20520, Finland|Frankfurt, Hessen, 60596, Germany|Köln, Nordrhein-Westfalen, 50968, Germany|Dresden, Sachsen, 01277, Germany|Wermsdorf, Sachsen, 04779, Germany|Wedel, Schleswig-Holstein, 22880, Germany|Erfurt, Thüringen, 99084, Germany|Berlin, 13353, Germany|Afula, 1834111, Israel|Ashkelon, 7830604, Israel|Hadera, 3810101, Israel|Petah Tikva, 4941492, Israel|Rehovot, 7610001, Israel|Tel Aviv, 64239, Israel|Zefat, 1311001, Israel|Oslo, 0450, Norway|Stavanger, Norway|Krakow, 30-082, Poland|Piotrkow Trybunalski, 97-635, Poland|Szczecin, 70-965, Poland|Warszawa, 04-635, Poland|Wroclaw, 50-981, Poland|Kristianstad, 29185, Sweden|Lund, 222 21, Sweden|Stockholm, 111 35, Sweden|Stockholm, 118 83, Sweden|Stockholm, Sweden
URL: https://clinicaltrials.gov/show/NCT01345656

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D119 Spironolactone small molecule DB00421 Details